Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic insights into the neuroprotective potential of gut microbiota-derived urolithins in Alzheimer's disease.

Mechanisms of ageing and development·2026
Same author

Short-chain fatty acids, neuroinflammation, and autism spectrum disorders: A mechanistic systematic review.

Journal of neuroimmunology·2026
Same author

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta<sub>1-42</sub>-induced neurodegeneration.

Mechanisms of ageing and development·2026
Same author

Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same author

Polyphenol-Microbiota Interactions in Atherosclerosis: The Role of Hydroxytyrosol and Tyrosol in Modulating Inflammation and Oxidative Stress.

Nutrients·2025
Same author

Biological Activities Underlying the Cardiovascular Benefits of Olive Oil Polyphenols: Focus on Antioxidant, Anti-Inflammatory, and Anti-Atherogenic Effects.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jun 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.

Hicham Berrougui1, Abdelouahed Khalil

  • 1Research Center on Aging, Sherbrooke University Geriatric Institute, Sherbrooke, Quebec, Canada.

Rejuvenation Research
|May 2, 2009
PubMed
Summary
This summary is machine-generated.

High-density lipoproteins (HDL) protect against atherosclerosis by removing cholesterol. Aging impairs this cholesterol efflux, disrupting cholesterol homeostasis and physiological functions.

More Related Videos

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Experiment Videos

Last Updated: Jun 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Area of Science:

  • Cardiovascular Biology
  • Lipid Metabolism
  • Aging Research

Background:

  • High-density lipoproteins (HDL) are atheroprotective, counteracting low-density lipoprotein (LDL) oxidation and inflammation.
  • Cholesterol efflux is a key mechanism for HDL's antiatherogenic effects and maintaining cholesterol homeostasis.
  • Several proteins and pathways, including SR-BI, ABCA1, ABCG1, LXR/RXR, PPARγ, apoA-I, LCAT, and phospholipids, mediate cholesterol transport.

Purpose of the Study:

  • To review the mechanisms of HDL-mediated cholesterol efflux.
  • To summarize the factors affecting cholesterol efflux.
  • To highlight the impact of aging on cholesterol efflux and homeostasis.

Main Methods:

  • Literature review of studies on HDL function, cholesterol transport, and aging.
  • Analysis of molecular mediators and pathways involved in cholesterol efflux.
  • Examination of factors influencing cholesterol efflux, including genetic and lifestyle elements.

Main Results:

  • Cholesterol efflux occurs via aqueous diffusion, SR-BI, ABCA1, and ABCG1 pathways.
  • ABCA1 facilitates unidirectional cholesterol transport mainly to lipid-poor apoA-I.
  • ABCG1 mediates cholesterol transport to various HDL subclasses.
  • HDL-mediated efflux involves apoA-I and potentially PON1.
  • Aging alters HDL composition and structure, impairing cholesterol efflux and physiological functions.

Conclusions:

  • Aging disrupts cholesterol homeostasis due to dysfunctional cholesterol efflux.
  • Impaired cholesterol efflux in aging leads to compromised physiological functions.
  • Understanding these mechanisms is crucial for addressing age-related cardiovascular risks.